Aurinia Pharmaceuticals (AUPH) Hits $13.45 52-Week High After 80% Surge
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a biopharmaceutical company headquartered in Victoria, British Columbia, with a mission to transform…
Aurinia Pharmaceuticals (AUPH) Hits 52-Week High
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a biopharmaceutical company dedicated to advancing treatments for serious autoimmune conditions that have…
Analysts Are Bullish: Could Aurinia (AUPH) Be the Next Billion-Dollar Biotech Winner?
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for the treatment of…
Aurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…